Thank you for downloading this publication. Please let us know why you chose this publication:
Why are you interested in this publication?
What organisation do you represent?
You will only need to complete this form once per browser/device
How do you prefer to read or receive publications?

We may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Malaria Consortium US Donate
  • About us
    • Who we are
    • Our Strategy
    • Governance
    • Aid transparency
  • Projects
  • Where We Work
  • What we do
    • Diseases
    • Our responses
    • Burden reduction to elimination
    • Data-informed decision-making & digital approaches
    • Health sector resilience
    • Research & policy change
    • Networks & partnerships
  • News & Resources
    • News
    • Blog
    • Videos
    • Webinars
    • Photo stories
  • Publications
    • Interactive publications
  • Support us
  • Contact Us
    • Newsletter
  • Work with us
    • Tenders
  • Home
  • »
  • Publications
  • »
  • Factors predicting adherence to day two and day three seasonal malaria chemoprevention administration in four Sahelian countries

Share this page

Resources

Latest

Publications

Publication Date:
16/11/2021

Author:
Taiwo Ibinaiye
Adaeze Aidenagbon
Chibuzo Oguoma
Olabisi Ogunmola
Olusola Oresanya
Sol Richardson

Type:
Poster
Publication

Factors predicting adherence to day two and day three seasonal malaria chemoprevention administration in four Sahelian countries

Publication Date:
16/11/2021
Author:
Taiwo Ibinaiye
Adaeze Aidenagbon
Chibuzo Oguoma
Olabisi Ogunmola
Olusola Oresanya
Sol Richardson
Type:
Poster

Seasonal malaria chemoprevention (SMC) involves monthly administration of sulfadoxine–pyrimethamine (SP) and amodiaquine (AQ) during the peak transmission season to prevent malaria among children 3–59 months. The treatment regimen comprises administration of one dose each of SP and AQ on the first day (day 1) under the supervision of SMC community distributors, while daily doses of AQ are administered by caregivers on days 2 and 3. Non-adherence to administration of day 2 and 3 AQ may make children susceptible to infection, and contribute to SP and AQ resistance in circulating parasites. We investigated predictors of adherence to day 2 and 3 AQ among eligible children in Burkina Faso, Chad, Nigeria and Togo during the last cycle of the 2020 SMC round (October). In Nigeria, these included home visits within the Lead Mothers programme, in which female community members conduct health promotion activities.

This poster was presented at the 70th annual meeting of the American Society of Tropical Medicine and Hygiene.

Click here to download

Country: Burkina Faso | Chad | Nigeria | Togo

Keywords: Community delivery | Child and maternal health | Malaria | Seasonal malaria chemoprevention | SDG3

 

 

« Back to Publications

Sign up for our newsletter here:

Follow us on our social channels
  • Jobs
  • Contact us
  • Annual reviews
  • Support us
  • About us
  • Sitemap
  • Policies
  • Modern Slavery Statement
Fundraising Regulator logo
© 2023 Malaria Consortium | Charity No. 1099776 | Company No. 4785712